Recent Finacing
Recent Raise
Chance Pharmaceuticals is a Hangzhou-based clinical-stage biotech developing dry powder inhalation drug/device therapies, with milling/mixing and spray-drying platforms, integrated R&D and FDA/EMA-compliant manufacturing, targeting respiratory, CNS, and fibrotic disorders.
